National Cancer Institute; Notice of Closed Meetings, 4494 [2019-02471]

Download as PDF 4494 Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator— Initiated Clinical Trial Planning Grant (R34). Date: March 19, 2019. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Priti Mehrotra, Ph.D., Chief, Immunology Review Branch, Scientific Review Program, Division of Extramural Activities, Room #3G40, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–7616, 240–669– 5066, pmehrotra@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 11, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02423 Filed 2–14–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKBBV9HB2PROD with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would VerDate Sep<11>2014 19:41 Feb 14, 2019 Jkt 247001 constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors for Basic Sciences National Cancer Institute. Date: July 8, 2019. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Porter Neuroscience Building, 35 Convent Drive, Building 35 Bethesda, MD 20892. Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center, Room 3W302, Bethesda, MD 20892– 9750, 240–276–5664, tondravim@ mail.nih.gov. Name of Committee: Board of Scientific Counselors for Clinical Sciences and Epidemiology National Cancer Institute. Date: July 9, 2019. Time: 9:00 a.m. to 3:45 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Porter Neuroscience Building, 35 Convent Drive, Building 35 Bethesda, MD 20892. Contact Person: Brian E. Wojcik, Ph.D. Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center, Room 3W414, Bethesda, MD 20892–9750, 240–276– 5664 wojcikb@mail.nih.gov. Name of Committee: Board of Scientific Counselors for Clinical Sciences and Epidemiology National Cancer Institute. Date: November 4, 2019. Time: 9:00 a.m. to 3:45 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Natcher Building, Conference Room D, 45 Center Drive, Bethesda, MD 20892. Contact Person: Brian E. Wojcik, Ph.D. Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center, Room 3W414, Bethesda, MD 20892–9750, 240–276– 5664 ,wojcikb@mail.nih.gov. Name of Committee: Board of Scientific Counselors for Basic Sciences, National Cancer Institute. Date: November 5, 2019. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Natcher Building, Conference Room D, 45 Center Drive, Bethesda, MD 20892. Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center, Room 3W302, Bethesda, MD 20892– 9750, 240–276–5664, tondravim@ mail.nih.gov. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02471 Filed 2–14–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Review Committee. Date: March 7–8, 2019. Time: 10:30 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westin Crystal City, 1800 Jefferson Davis Highway, Alexandria, VA 22202. Contact Person: Keith A. Mintzer, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 20892–7924, 301–827– 7949, mintzerk@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) E:\FR\FM\15FEN1.SGM 15FEN1

Agencies

[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Page 4494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02471]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors for Basic 
Sciences National Cancer Institute.
    Date: July 8, 2019.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Porter Neuroscience 
Building, 35 Convent Drive, Building 35 Bethesda, MD 20892.
    Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute 
Review Office, Office of the Director, National Cancer Institute, 
National Institutes of Health, 9609 Medical Center, Room 3W302, 
Bethesda, MD 20892-9750, 240-276-5664, tondravim@mail.nih.gov.

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology National Cancer Institute.
    Date: July 9, 2019.
    Time: 9:00 a.m. to 3:45 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Porter Neuroscience 
Building, 35 Convent Drive, Building 35 Bethesda, MD 20892.
    Contact Person: Brian E. Wojcik, Ph.D. Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center, Room 3W414, Bethesda, MD 20892-9750, 240-276-5664 
wojcikb@mail.nih.gov.

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology National Cancer Institute.
    Date: November 4, 2019.
    Time: 9:00 a.m. to 3:45 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Natcher Building, 
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Brian E. Wojcik, Ph.D. Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center, Room 3W414, Bethesda, MD 20892-9750, 240-276-5664 
,wojcikb@mail.nih.gov.

    Name of Committee: Board of Scientific Counselors for Basic 
Sciences, National Cancer Institute.
    Date: November 5, 2019.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Natcher Building, 
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute 
Review Office, Office of the Director, National Cancer Institute, 
National Institutes of Health, 9609 Medical Center, Room 3W302, 
Bethesda, MD 20892-9750, 240-276-5664, tondravim@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: February 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02471 Filed 2-14-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.